Navigation Links
Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors

SALT LAKE CITY, Nov. 5, 2012 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, announced today that esteemed financial executive Jay M. Moyes has been elected to its Board of Directors.

Mr. Moyes brings more than 30 years of management and leadership experience to the Amedica Board of Directors.  He has been instrumental in the financial development and expansion of some of the medical industry's most groundbreaking companies including Myriad Genetics, where he guided the company through its initial public offering.  Mr. Moyes currently sits on the Board of Directors with multiple biotechnology companies including Osiris Therapeutics Inc., Biocardia Inc., Integrated Diagnostics Inc., and Puma Biotechnology Inc.  He formerly held a Board position with the Utah Life Science Industry Association.

"Jay brings a unique perspective to the Amedica leadership team.  His experience and insight are incredibly valued as we work to further establish Amedica's position in the orthopedic industry," said Eric K. Olson, President and Chief Executive Officer, Amedica.  "We look forward to drawing on the depth of his knowledge and business expertise as we expand our market penetration and continue developing innovative products that provide both clinical and economic value."

Throughout Mr. Moyes's career, he has worked with numerous industry-leading companies through their transformation from emerging growth to established, publicly-traded companies.  Most recently, he served as Chief Financial Officer at XDX, an emerging molecular diagnostics company.  Previously he served in the same role at Myriad Genetics, a publicly traded, leading biotechnology company focused on molecular diagnostics and therapeutic development.  Prior to Myriad, Mr. Moyes served as Chief Financial Officer of Genmark, an agricultural biotechnology company, and as a Senior Manager with the international public accounting firm of KPMG.  He holds a Masters in Business Administration from the University of Utah and received his undergraduate degree in economics from Weber State University.

About AMEDICA Corporation:

Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications including silicon nitride ceramic technologies. The company's platform technologies represent a new standard for implants and biologics based on superior performance, safety and efficacy.  Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.

Media Contact
Stacey Holifield / Heather McIntyre
Schwartz MSL
(781) 684-0770


SOURCE Amedica Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
3. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
4. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
5. Bausch + Lomb Names John Barr Global President Surgical
6. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
7. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
8. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
9. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
10. MedVantx Names New VP Employer Solutions and Workplace Health
11. Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Post Your Comments:
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/28/2015)... , ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until ... most savings. , With possible savings of up to 20% off orders $80 or more ... of the website every few hours. , As a competitive e-commerce website for skin care ...
(Date:11/27/2015)... CO (PRWEB) , ... November 27, 2015 , ... According ... cities are not changing the way that they are handling security in light of ... police and security presence in an attempt to stop an attack from reaching U.S. ...
(Date:11/27/2015)... County, CA (PRWEB) , ... November 27, 2015 , ... ... season , The company is offering customers 10% off of their purchase of lice ... any treatment at full price. According to a company spokesperson. “Finding lice is a ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for ... of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and women on ... organizations in the country. They have overseen financial turnarounds, shown commitment to their ... healthcare industry as a whole through their advocacy and professional efforts. , Becker's ...
Breaking Medicine News(10 mins):